Pre-Open Movers 7/28: Amgen (AMGN) Up On Positive osteoporosis Trial; Vanda (VNDA) Sinks On FDA 'Not Approvable"
Tweet Send to a Friend
StreetInsider.com Pre-Open Movers:
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) 57% LOWER; received a not approvable letter from the FDA in response ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) 57% LOWER; received a not approvable letter from the FDA in response ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
